No abstract available
MeSH terms
-
Anti-Infective Agents / therapeutic use
-
Anti-Ulcer Agents / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Busulfan / adverse effects
-
Combined Modality Therapy
-
Cyclophosphamide / adverse effects
-
Cytarabine / administration & dosage
-
Cytarabine / adverse effects
-
Dilatation
-
Esophageal Stenosis / etiology*
-
Esophagitis / chemically induced*
-
Esophagitis / complications
-
Esophagitis / therapy
-
Etoposide / administration & dosage
-
Etoposide / adverse effects
-
Hematopoietic Stem Cell Transplantation
-
Humans
-
Leukemia, Myelomonocytic, Acute / complications*
-
Leukemia, Myelomonocytic, Acute / drug therapy
-
Male
-
Middle Aged
-
Recurrence
-
Remission Induction
-
Transplantation Conditioning / adverse effects
-
Ulcer / chemically induced*
-
Ulcer / complications
-
Ulcer / therapy
Substances
-
Anti-Infective Agents
-
Anti-Ulcer Agents
-
Cytarabine
-
Etoposide
-
Cyclophosphamide
-
Busulfan